Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
Business Wire
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today..
Clostridioides difficile infection
News and Video Search Results
News coverage
-
Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024
GlobeNewswire
-
Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications
GlobeNewswire
-
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
GlobeNewswire
-
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
GlobeNewswire
- More about:
Clostridioides difficile infection
0 shares
1 views
You might like
Clostridioides difficile infection media coverage
Ayr Hospital had to deal with recent outbreak of bacterial infection
Daily Record
Symptoms of a Clostridioides difficile infection include diarrhoea, a high temperature and feeling sick.
-
Microbiome Therapeutics Market is set to Reach US$ 909.20 million at a CAGR of 28.2% from the forecast period 2023 to 2031 | Growth Plus Reports
GlobeNewswire
-
Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?
Upworthy
-
Immuron Clinical Trials Update
GlobeNewswire
-
Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD
GlobeNewswire
Advertisement
More coverage
Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn
GlobeNewswire
· VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available through major retail..
-
Chlorine Disinfectant Is No More Effective Than Water At Killing Off Hospital Superbug
Eurasia Review
-
New to The Street Announces Episode 530 with Six Corporate Interviews, Airing on the Fox Business Network, Monday, November 20, 2023, at 10:30 PM PT
GlobeNewswire
-
CU Medicine develops novel microbiome technology MOZAICTM for faecal microbiota transplantation
PR Newswire Asia
-
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults
GlobeNewswire